The Association of Clinical Research Professionals

Webinar Replay: Generally Recognized as Safe Regulatory Requirements

Pricing With Contact Hours

Member: $15 | Nonmember: $75

Add to Cart

This course is approved for 1.0 ACRP contact hours. Accreditation Details

Webinar Replay Expires May 22, 2019.


Pricing Without Contact Hours

Member: $0 | Nonmember: N/A

Add to Cart

Webinar Replay Expires May 22, 2019.


Course Description

After publication of the draft Generally Regarded As Safe (GRAS) rule in 1977, the United States Food and Drug Administration (FDA) initiated an Interim Pilot Program encouraging the notification to FDA of GRAS determinations. This presentation analyzes GRAS notifications submitted during the Interim Pilot program along with warning letters issued during the same time period to better understand the evolution of the program and anticipate the future GRAS landscape. GRAS Notifications revealed interesting trends regarding the inclusion and composition of GRAS Expert Panels; differences in notifications for substances with nutritive, processing aid, or effect; and the duration of GRAS Notifications. The review of FDA warning letters associated with GRAS issues provides additional insight into GRAS notices, from the perspective of ongoing post-market emphasis on food safety with the implementation of the GRAS Final Rule.

Upon completion of this Webinar, attendees should be able to:

  1. Understand basic GRAS history
  2. Become familiar with the GRAS process
  3. Identify trends and evolution of the GRAS Notification program